Best_Practice_guidelines_on_Nitrosamines_and_NDSRIs_in_Pharma_Products
0 likes | 21 Views
Nitrosamine Drug Substance Related Impurities (NDSRIs) are potential carcinogens that can form in drug products under certain conditions. Regulatory agencies like the FDA and EMA have set strict limits and testing guidelines to ensure drug safety. Manufacturers must assess and control NDSRI risks during drug development and production. <br><br>Know more here- https://www.ipa-india.org/wp-content/uploads/2025/02/Best_Practice_guidelines_on_Nitrosamines_and_NDSRIs_in_Pharma_Products.pdf
Download Presentation 
Best_Practice_guidelines_on_Nitrosamines_and_NDSRIs_in_Pharma_Products
An Image/Link below is provided (as is) to download presentation
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.
Content is provided to you AS IS for your information and personal use only.
Download presentation by click this link.
While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
During download, if you can't get a presentation, the file might be deleted by the publisher.
E N D
Presentation Transcript
More Related